Abstract
Objectives: Infectious complications occur in upto 45% of patients following pancreatoduodenectomy (PD) and are higher in patients undergoing preoperative endoscopic invasive procedures. Surgical morbidity adversely affects long-term outcomes and thus role of perioperative antimicrobials needs evaluation. The aim of the study was to compare the impact of Ertapenem administered as 3-once daily perioperative doses on infectious complications in patients at high-risk for complications (underwent preoperative invasive endoscopic procedures) versus those at low-risk (up-front surgery).
| Original language | English |
|---|---|
| Pages (from-to) | e418 |
| Number of pages | 1 |
| Journal | HPB |
| Volume | 18 |
| Issue number | Supplement 1 |
| DOIs | |
| Publication status | Published - Apr 2016 |
| Externally published | Yes |
Keywords
- Perioperative
- antimicrobial
- therapy
- pancreatoduodenectomy